In clinical studies, Laske et al., discovered that a large recombinant toxin, Tf-CRM107, a conjugate of Tf and a genetic mutant of diphtheria toxin (CRM107), was successfully delivered into a malignant brain tumor and penetrated into the nearby brain tissue via CED. This evidence concerns the gene TF and brain cancer.